IONS - Ionis Pharmaceuticals GAAP EPS of -$1.03 in-line revenue of $144M beats by $7.62M
2023-11-02 07:03:11 ET
More on Ionis Pharmaceuticals
- Ionis Pharmaceuticals: Mid-Sized Pharma Is A Strong Buy Opportunity For All-Comers
- Ionis Pharmaceuticals, Inc. (IONS) Q2 2023 Earnings Call Transcript
- Ionis Pharmaceuticals Q3 2023 Earnings Preview
- Biogen updates Phase 1 data for Ionis-partnered Alzheimer’s drug
- Seeking Alpha’s Quant Rating on Ionis Pharmaceuticals
For further details see:
Ionis Pharmaceuticals GAAP EPS of -$1.03 in-line, revenue of $144M beats by $7.62M